Approach: Epidemiologic Research (Quantitative)
Tags: Zambia; Child Survival; Neonatal Survival; Neonatal and Child Survival
Approaches: Capacity Strengthening; Epidemiologic Research (Quantitative); Evaluation Research and Validation
Tags: Global; Child Survival; Community-Based Access; Health Systems Strengthening & Financing; Neonatal and Child Survival; Nutrition; Pharmaceutical Access, Innovation, and Use; Service Delivery Models
Tags: Global; Child Survival; Community-Based Access; Health Systems Strengthening & Financing; Malaria; Neonatal Survival; Neonatal and Child Survival; Nutrition; Pharmaceutical Access, Innovation, and Use; Pharmaceutical Policy; Pneumonia; Service Delivery Models
Approaches: Capacity Strengthening; Clinical Trial; Community Based; Economic Analysis; Epidemiologic Research (Quantitative); Evaluation Research and Validation; Qualitative Research
Tags: Global; Adherence; Applied Economics; Child Survival; HIV/AIDS; Health Systems Strengthening & Financing; Malaria; Neonatal Survival; Neonatal and Child Survival; Pneumonia; Poverty & Development; Quality of Care; Service Delivery Models; Social Policy
Approaches: Economic Analysis; Epidemiologic Research (Quantitative)
Tags: Kenya; Applied Economics; HIV/AIDS; Orphans and Vulnerable Children (OVC); Poverty & Development; Social Policy
Approaches: Capacity Strengthening; Economic Analysis; Epidemiologic Research (Quantitative)
Tags: Kenya; Applied Economics; Benefits of Treatment; HIV/AIDS; Health Systems Strengthening & Financing; Pharmaceutical Access, Innovation, and Use; Pharmaceutical Policy; Public Private Partnerships; Quality of Care; Service Delivery Models
Tags: South Africa; Applied Economics; Benefits of Treatment; Cost & Cost-Effectiveness; HIV/AIDS; Health Systems Strengthening & Financing; Improving Treatment Outcomes
Tags: South Africa; Applied Economics; Financing and Supply of Services; HIV/AIDS; Impacts of HIV/AIDS; Service Delivery Models
Tags: South Africa; Applied Economics; HIV/AIDS; Health Systems Strengthening & Financing; Pharmaceutical Access, Innovation, and Use; Quality of Care; Service Delivery Models
Approaches: Epidemiologic Research (Quantitative); Evaluation Research and Validation; Qualitative Research
Tags: Ethiopia; Health Systems Strengthening & Financing; Orphans and Vulnerable Children (OVC)
Tags: Malawi; HIV/AIDS; Orphans and Vulnerable Children (OVC); Poverty & Development; Sex, Sexuality, Gender, and Health; Social Policy
Tags: Zambia; Adherence; Applied Economics; HIV/AIDS; Health Systems Strengthening & Financing; Improving Treatment Outcomes; Pharmaceutical Access, Innovation, and Use; Quality of Care
Tags: Zambia; Applied Economics; Health Systems Strengthening & Financing; Impacts of HIV/AIDS; Pharmaceutical Access, Innovation, and Use
Tags: Mozambique; HIV/AIDS; Orphans and Vulnerable Children (OVC); Poverty & Development
Tags: South Africa; Applied Economics; HIV/AIDS; Health Systems Strengthening & Financing; Improving Treatment Outcomes; Pharmaceutical Access, Innovation, and Use; Quality of Care; Service Delivery Models
Tags: South Africa; HIV/AIDS; Improving Treatment Outcomes
Approaches: Capacity Strengthening; Economic Analysis; Epidemiologic Research (Quantitative); Evaluation Research and Validation; Qualitative Research
Tags: Global; HIV/AIDS; Orphans and Vulnerable Children (OVC); Poverty & Development
Tags: Zambia; Child Survival; Neonatal Survival; Neonatal and Child Survival; Pneumonia
Approaches: Epidemiologic Research (Quantitative); Qualitative Research
Tags: India; Malaria; Neonatal and Child Survival
Tags: Global; Applied Economics; HIV/AIDS; Orphans and Vulnerable Children (OVC)
Approaches: Capacity Strengthening; Epidemiologic Research (Quantitative)
Tags: South Africa; Education; HIV/AIDS; Orphans and Vulnerable Children (OVC); Poverty & Development
Approaches: Clinical Trial; Epidemiologic Research (Quantitative); Evaluation Research and Validation
Tags: Zambia; Child Survival; HIV/AIDS; Impacts of HIV/AIDS; Neonatal and Child Survival; Pneumonia
Tags: South Africa; Applied Economics; Cost & Cost-Effectiveness; HIV/AIDS; Health Systems Strengthening & Financing; Improving Treatment Outcomes; Pharmaceutical Access, Innovation, and Use; Quality of Care; Service Delivery Models
